BioSpace News Archive

Biotech Bay

DiaCarta Scores $45M Series B to Expand Its Liquid Biopsy Cancer Detection Platform & Services

The second closing was led by Fortune Fountain Capital and was also subscribed to by Good Health Capita.

February 12, 2018

·

3 min read

Biotech Beach

DexCom Announces Upcoming Raymond James & Associates’ 39th Annual Institutional Investors Conference Presentations

The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.

February 12, 2018

·

1 min read

Business

10x Genomics Announces New Partnership Programs

10x Genomic today announced a global partnership ecosystem to accelerate customer adoption of 10x Genomics’ sequencing applications through the Certified Service Provider and 10x Compatible Programs.

February 12, 2018

·

3 min read

Biotech Bay

Aimmune Therapeutics Announces Presentations at 2018 AAAAI-WAO Joint Congress

Aimmune Therapeutics today announced that it will present data during a late-breaking oral abstract session and in poster sessions at the 2018 American Academy of Allergy, Asthma & Immunology–World Allergy Organization Joint Congress, taking place March 2–5 in Orlando.

February 12, 2018

·

4 min read

Business

Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation

Neptune and Tetra Bio-Pharma announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets.

February 12, 2018

·

5 min read

Business

Advanced Accelerator Applications Signs Exclusive License Agreement With Cancer Targeted Technology to Develop CTT1057, an F-18 Labeled PSMA Ligand for Diagnostic Applications in Prostate Cancer

The terms of the agreement include an upfront licensing fee, as well as certain milestone and royalty payments.

February 12, 2018

·

5 min read

Propanc Biopharma Provides Shareholder Update and Goals for 2018

Since the beginning of 2017, the Company has initiated and completed a number of activities.

February 12, 2018

·

6 min read

Drug Development

CBSET: Preclinical Safety Studies Must Include Equally Balanced Male/Female Animal Models to Shed Light on Sex-Dependent Vascular Responses in Humans

CBSET announced today that its scientists have published data and analyses (“Sex differences in the outcomes of stent implantation in mini-swine model”) that “illustrate differences in the dynamic healing responses of male and female pigs to stent implantation in single and overlapped configurations.”

February 12, 2018

·

4 min read

Policy

Icon Bioscience Receives FDA Approval for DEXYCU, a Potentially Transformational Drug Therapy for Treating Inflammation Associated with Cataract Surgery

The company noted that in the U.S. alone, over four million cataract surgeries are performed annually.

February 12, 2018

·

3 min read

Business

Horizon Discovery Enters into License Agreement With US Immuno-Oncology Company

Under the terms of the agreement, Horizon has licensed to the Partner a novel cell line engineering technology as well as non-exclusive rights to Horizon’s proprietary Helitron transposon gene editing technology for an undisclosed financial consideration.

February 12, 2018

·

2 min read